Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

 

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Avatar

DVT Prophylaxis in Higher-Risk VTE Cancer Patients: Outcomes of AVERT (Apixaban) and CASSINI (Rivaroxaban) Trials

By Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019 FEATURING Stephan Moll
By Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019 FEATURING Stephan Moll
93 views
May 28, 2019
0 Comments
Login to view comments. Click here to Login
Nonmalignant Hematology
15:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Historical Overview of PEX Therapy in TTP

Feat. J. Kelton
13:14
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Measuring ADAMTS13 Levels in TTP: New Findings

Feat. J. Kelton
13:29
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Update on TTP Treatment: PEX, Antibody or Nanobody?

Feat. J. Kelton
05:27
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Summary of Hemolytic-Uremic Syndrome in 2019: From Types and Diagnos…

Feat. J. Kelton
28:10
Scripps MD Anderson Cancer Center

Thrombosis in Cancer Patients: Vitamin K Antagonists and Direct Oral…

Feat. J. Douketis
11:11
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Diagnosing Models for Advanced Systemic Mastocytosis

Feat. J. Gotlib
12:37
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Treatment Considerations for Advanced Systemic Mastocytosis

Feat. J. Gotlib
10:00
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Eosinophilia and Eosinophilia-Associated Myeloid/Lymphoid Neoplasms:…

Feat. J. Gotlib
10:22
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Treating Eosinophilia-Associated Myeloid/Lymphoid Neoplasms: TKI-Tar…

Feat. J. Gotlib
12:14
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Best Treatment for VTE in Cancer Patients: DOACs vs. LMWH

Feat. S. Moll
10:45
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

DVT Prophylaxis in Higher-Risk VTE Cancer Patients: Outcomes of AVER…

Feat. S. Moll
09:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

2018/2019 DOACs Update on Obesity, Bariatric Surgery, Antiphospholip…

Feat. S. Moll
17:19
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

How Long and How to Treat VTE? Anticoagulation Therapy, Recurrence T…

Feat. S. Moll
04:14
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Approach to Neutrophilic Leukocytosis: General Testing Algorithm - J…

Feat. B. Reeves
34:00
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Approach to Erythrocytosis: General Testing Algorithm - JAK2 and EPO…

Feat. B. Reeves
12:44
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Approach to Thrombocytosis: General Testing Algorithm - JAK2, BCR-AB…

Feat. B. Reeves
54:04
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

MGUS: Disease Definitions, Diagnostic Approaches and Risk Stratifica…

Feat. M. Gertz
22:14
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Gamechanger in Hemophilia Treatment: rVWF, Antibody and Gene Therapy

Feat. A. Ma